3551 - 3600 of 8399 Results
Title
Year
-
OPENTitle: Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central EuropeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 48End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.026Best OA location URL: http://manuscript.elsevier.com/S135380202100119X/pdf/S135380202100119X.pdfCitation Count: 12
- Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐Analysis2021RESTRICTEDTitle: Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1293End Page: 1307Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28599Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/238481/238481.pdfCitation Count: 20
-
RESTRICTEDTitle: ATP1A3-Related Disorders: An Ever-Expanding Clinical SpectrumJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.637890Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.637890/pdfCitation Count: 32
-
OPENTitle: Cerebello‐Cortical Control of Tremor Rhythm and Amplitude in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1727End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28603Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/238510/238510.pdfCitation Count: 32
-
OPENTitle: Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platformsJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/jev2.12079Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12079Citation Count: 147
- Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments2021RESTRICTEDTitle: Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New TreatmentsJournal Name: Archives of Medical ResearchPublisher: Elsevier BVVol: 52Issue #: 3Start Page: 243End Page: 251Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arcmed.2020.10.021Citation Count: 25
-
RESTRICTEDTitle: Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysisJournal Name: CancerPublisher: WileyVol: 127Issue #: 14Start Page: 2409End Page: 2422Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cncr.33516Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.33516Citation Count: 75
-
OPENTitle: Evidence forGRNconnecting multiple neurodegenerative diseasesJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab095Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/2/fcab095/41728465/fcab095.pdfCitation Count: 33
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://repositorio.uca.edu.ar/bitstream/123456789/11645/6/fluoxetine-symptomatic-treatment-atrophy%20%281%29.pdfCitation Count: 21
-
RESTRICTEDTitle: Genetic updates on paroxysmal dyskinesiasJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 128Issue #: 4Start Page: 447End Page: 471Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-021-02335-xCitation Count: 8
-
OPENTitle: Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor SubtypesJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000557Best OA location URL: https://ng.neurology.org/content/nng/7/2/e557.full.pdfCitation Count: 38
-
RESTRICTEDTitle: Intersection of immunometabolism and immunosenescence during agingJournal Name: Current Opinion in PharmacologyPublisher: Elsevier BVVol: 57Issue #:Start Page: 107End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.coph.2021.01.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481958Citation Count: 21
-
RESTRICTEDTitle: Mindfulness based stress reduction in people with Parkinson's disease and their care partnersJournal Name: Complementary Therapies in Clinical PracticePublisher: Elsevier BVVol: 43Issue #:Start Page: 101377End Page: 101377Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ctcp.2021.101377Citation Count: 11
-
OPENTitle: Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozinJournal Name: NeoplasiaPublisher: Elsevier BVVol: 23Issue #: 4Start Page: 391End Page: 399Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neo.2021.02.003Best OA location URL: https://doi.org/10.1016/j.neo.2021.02.003Citation Count: 16
-
OPENTitle: Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette SyndromeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 694End Page: 700Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13207Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13207Citation Count: 6
-
OPENTitle: Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab109Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/2/fcab109/41723515/fcab109.pdfCitation Count: 35
-
OPENTitle: Variable number tandem repeats – Their emerging role in sickness and healthJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 246Issue #: 12Start Page: 1368End Page: 1376Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1177/15353702211003511Best OA location URL: https://doi.org/10.1177/15353702211003511Citation Count: 19
-
OPENTitle: Will Artificial Intelligence Outperform the Clinical Neurologist in the Near Future? NoJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 4Start Page: 529End Page: 531Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13200Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13200Citation Count: 2
-
RESTRICTEDTitle: Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 8Start Page: 3641End Page: 3652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02371-4Citation Count: 13
-
OPENTitle: Pervasive cis effects of variation in copy number of large tandem repeats on local DNA methylation and gene expressionJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 108Issue #: 5Start Page: 809End Page: 824Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2021.03.016Best OA location URL: http://www.cell.com/article/S0002929721001002/pdfCitation Count: 33
-
OPENTitle: Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity studyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2101Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119826Citation Count: 13
-
RESTRICTEDTitle: Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the StriatumJournal Name: Clinical Nuclear MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 46Issue #: 6Start Page: e296End Page: e306Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/rlu.0000000000003609Citation Count: 4
-
OPENTitle: Lipidomics Prediction of Parkinson’s Disease Severity: A Machine-Learning AnalysisJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1141End Page: 1155Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-202476Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355022Citation Count: 30
-
OPENTitle: Palliative Care and Parkinson's Disease: Time to Move Beyond CancerJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1325End Page: 1329Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28556Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217287Citation Count: 19
- Tablet-based patient educational interventions in care and management of complex movement disorders2021RESTRICTEDTitle: Tablet-based patient educational interventions in care and management of complex movement disordersJournal Name: Disability and Rehabilitation: Assistive TechnologyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 627End Page: 634Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17483107.2021.1900934Citation Count: 2
-
OPENTitle: Association of Mitochondrial DNA Genomic Variation With Risk of Pick DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000011649Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055308Citation Count: 2
-
OPENTitle: Tau induces formation of α-synuclein filaments with distinct molecular conformationsJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 554Issue #:Start Page: 145End Page: 150Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2021.03.091Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062303Citation Count: 24
-
RESTRICTEDTitle: Public Engagement and Neurology: An UpdateJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 4Start Page: 429End Page: 429Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11040429Best OA location URL: https://www.mdpi.com/2076-3425/11/4/429/pdf?version=1617937511Citation Count: 5
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/bitstream/123456789/11625/1/effects-angiotensin-1-type-receptor.pdfCitation Count: 11
-
OPENTitle: Folded concave penalized learning of high-dimensional MRI data in Parkinson’s diseaseJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 357Issue #:Start Page: 109157End Page: 109157Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jneumeth.2021.109157Best OA location URL: http://manuscript.elsevier.com/S0165027021000923/pdf/S0165027021000923.pdfCitation Count: 1
-
RESTRICTEDTitle: Magnetic resonance imaging quality control, quality assurance and quality improvementJournal Name: Pediatric RadiologyPublisher: Springer Science and Business Media LLCVol: 51Issue #: 5Start Page: 698End Page: 708Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00247-021-05043-6Citation Count: 8
-
OPENTitle: Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.645706Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.645706/pdfCitation Count: 20
- ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation system2021OPENTitle: ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation systemJournal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 9Start Page: 2013End Page: 2030.e9Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.03.001Best OA location URL: http://www.cell.com/article/S1097276521001696/pdfCitation Count: 70
- Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursing2021RESTRICTEDTitle: Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursingJournal Name: Archives of Psychiatric NursingPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 284End Page: 289Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.apnu.2021.03.006Citation Count: 6
-
RESTRICTEDTitle: Obtaining Objective Clinical Measures During Telehealth Evaluations of DysarthriaJournal Name: American Journal of Speech-Language PathologyPublisher: American Speech Language Hearing AssociationVol: 30Issue #: 2Start Page: 503End Page: 516Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1044/2020_ajslp-20-00243Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740561Citation Count: 16
-
OPENTitle: Assessment of ANG variants in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 104Issue #:Start Page: 111.e1End Page: 111.e4Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.03.006Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.03.006Citation Count: 1
-
OPENTitle: Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomesJournal Name: Current BiologyPublisher: Elsevier BVVol: 31Issue #: 10Start Page: 2140End Page: 2154.e6Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cub.2021.02.061Best OA location URL: http://www.cell.com/article/S0960982221003055/pdfCitation Count: 140
-
OPENTitle: Microdroplet-based one-step RT-PCR for ultrahigh throughput single-cell multiplex gene expression analysis and rare cell detectionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-86087-4Best OA location URL: https://www.nature.com/articles/s41598-021-86087-4.pdfCitation Count: 24
-
OPENTitle: Replication of a Novel Parkinson's Locus in a European Ancestry PopulationJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1689End Page: 1695Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28546Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28546Citation Count: 17
- Evaluation, Acceptance, and Qualification of Digital Measures: From Proof of Concept to Endpoint2021RESTRICTEDTitle: Evaluation, Acceptance, and Qualification of Digital Measures: From Proof of Concept to EndpointJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 5Issue #: 1Start Page: 53End Page: 64Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000514730Best OA location URL: https://www.karger.com/Article/Pdf/514730Citation Count: 37
-
OPENTitle: Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer’s Disease Using Post-mortem Brain Tissue SamplesJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.620899Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.620899/pdfCitation Count: 38
-
OPENTitle: Olfaction in Neuropathologically Defined Progressive Supranuclear PalsyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1700End Page: 1704Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28568Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972484Citation Count: 16
-
OPENTitle: Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9Journal Name: Gene TherapyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 6Start Page: 390End Page: 397Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41434-021-00244-yBest OA location URL: https://www.nature.com/articles/s41434-021-00244-y.pdfCitation Count: 31
-
OPENTitle: PARKIN, PINK1, and DJ1 analysis in early-onset Parkinson’s disease in IrelandJournal Name: Irish Journal of Medical Science (1971 -)Publisher: Springer Science and Business Media LLCVol: 191Issue #: 2Start Page: 901End Page: 907Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11845-021-02563-wBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376961Citation Count: 11
-
RESTRICTEDTitle: Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population‐Based CLSAJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1466End Page: 1467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28571Citation Count: 6
-
RESTRICTEDTitle: The cell biology of Parkinson’s diseaseJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 220Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1083/jcb.202012095Best OA location URL: https://rupress.org/jcb/article-pdf/220/4/e202012095/1412029/jcb_202012095.pdfCitation Count: 80
-
RESTRICTEDTitle: Transcriptome-wide Association Study in Frontotemporal Dementia Identifies New Disease Loci by In Silico AnalysisJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 89Issue #: 8Start Page: e37End Page: e39Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.02.010Citation Count: 0
-
OPENTitle: VPS35 D620N knockin mice recapitulate cardinal features of Parkinson’s diseaseJournal Name: Aging CellPublisher: WileyVol: 20Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13347Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13347Citation Count: 31
-
OPENTitle: Crowdsourcing digital health measures to predict Parkinson’s disease severity: the Parkinson’s Disease Digital Biomarker DREAM ChallengeJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41746-021-00414-7Best OA location URL: https://www.nature.com/articles/s41746-021-00414-7.pdfCitation Count: 42
-
RESTRICTEDTitle: Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experienceJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.653377Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.653377/pdfCitation Count: 19